Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
| Actual shortage: | 226 (7%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-08-04 | 2023-08-12 | 201171 |
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2023-09-07 | 2023-10-13 | 203849 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-09-28 | 2023-11-10 | 205489 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2023-09-28 | 2023-11-10 | 205498 |
| APO-NAPROXEN | 500MG | TABLET | Resolved | 2024-02-09 | 2024-04-26 | 219171 |
| APO-NAPROXEN | 500MG | TABLET | Actual shortage | 2024-03-15 | 2024-04-05 | 222478 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2018-02-21 | 2018-08-09 | 40354 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-01-15 | 2020-02-01 | 103370 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-12-04 | 2021-06-14 | 129608 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-04 | 2021-06-14 | 140423 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-09-24 | 2021-10-05 | 146157 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2022-01-14 | 2022-02-07 | 152770 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-11 | 2022-10-20 | 166445 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2022-10-20 | 166601 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-01-06 | 2023-03-02 | 180113 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2023-04-27 | 2023-06-23 | 190859 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2017-09-04 | 2018-07-31 | 20882 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-02-21 | 2018-05-01 | 40351 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-04 | 2018-12-28 | 54297 |
| APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2020-12-18 | 2021-01-19 | 130410 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |